New insulin system tested in hotel setting for type 1 diabetes
NCT ID NCT06834568
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new insulin delivery system called Tandem Freedom in 10 adults with type 1 diabetes. Participants used their usual system at home for a week, then switched to the new system in a supervised hotel setting. The goal was to check safety and how well it controls blood sugar levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Otago
Christchurch, 8140, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart insulin pump may boost brain and body health in older adults with diabetes
- Can a peer coach help young people take control of their chronic illness?
- Could a slightly lower threshold for treating low blood sugar prevent dangerous spikes in kids with diabetes?
- Carbs and kids: new study reveals how diet impacts diabetes control with smart pumps
- Gene test may predict who needs insulin
- New digital tool aims to simplify care for seniors with multiple conditions